Clinical Trial Update: Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating first-line docetaxel plus cisplatin for metastatic non-small cell lung cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: National Guard Health Affairs | Conditions: Non-small Cell Lung Cancer Metastatic | Phase 2 | Status: SUSPENDED